Edgewise Therapeutics announced topline data from Phase 1 and Phase 2 trials of EDG-7500 for obstructive hypertrophic ...

LVEF indicates left ventricular ejection fraction; RASi, renin‐angiotensin system inhibitors ... In those with baseline and 1‐year CMR, the result was evaluated and compared. Right and left ...

Background Pregnant patients with single ventricle (SV) physiology carry a high risk of spontaneous pregnancy loss (SPL), yet the clinical factors contributing to this risk are not well defined.

Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and ...

With the heart failure (HF) patient population rapidly expanding, the timing is right for Bayer’s ... HF patients with a left ventricle ejection fraction (LVEF) of more than 40%, the company ...

CMR showed isolated left ventricular crypt with mild hypertrophy of myocardial wall, preserved ejection fraction, no hyperintensity in the ... suggestive of HCM or arrhythmogenic dysplasia of the ...

During the first quarter of fiscal year 2025 (“Q1 FY2025”), HeartSciences has seen material progress for both its MyoVista wav ECG TM device, MyoVista Insights TM cloud-platform and associated first ...

Results of the HELIOS-B trial indicate patients may soon have a second drug class available to slow the progression of ...

Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical ...

Figure 4. Decision curve analysis of the right ventricular remodelling patterns for risk prediction. AV, aortic valve; FAC, fraction area change; LVEDV, left ventricular end-diastolic volume; LVEF, ...

One of the proposed explanations for the exertional elevation of LV filling pressures in patients with heart failure with preserved ejection fraction (HFPEF) is a steep diastolic pressure–volume ...